A Phase 1 study of AS-S603 in healthy participants
Recruiting Phase 1 NCT06786676
Study Description
A Phase 1 clinical trial to evaluate the safety, tolerability, and pharmacokinetics of an investigational drug (AS-S603) in healthy adults and elderly individuals
Study Details
- Registry ID:
- NCT06786676
- Conditions:
- Healthy
- Phase:
- Phase 1
- Target Enrollment:
- 88 participants
- Start Date:
- Healthy Volunteers:
- No
Study Locations (2 sites)
-
Seoul National University Hospital Clinical Trial Center
Seoul, Korea, Republic of -
Seoul National University Hospital Clinical Trial Center
Seoul, South Korea
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.